Cardiovascular Research

Article	Citations
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options	979
Global burden of heart failure: a comprehensive and updated review of epidemiology	514
Cardiac fibrosis	409
Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science	311
Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19	246
Regional and global contributions of air pollution to risk of death from COVID-19	209
Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities	193
Vascular smooth muscle cells in atherosclerosis: time for a re-assessment	171
SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes	170
Endothelial function in cardiovascular medicine: a consensus paper of the European Society of Cardiology Working Groups on Atherosclerosis and Vascular Biology, Aorta and Peripheral Vascular Diseases,	159
Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation	159
Angiogenesis after acute myocardial infarction	144
The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction	101
Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome	100
Metabolic inflammation in heart failure with preserved ejection fraction	99
Neutrophil extracellular traps: from physiology to pathology	95
Single-cell RNA sequencing reveals the cellular heterogeneity of aneurysmal infrarenal abdominal aorta	94
Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute Card	91
Evidence of SARS-CoV-2 mRNA in endomyocardial biopsies of patients with clinically suspected myocarditis tested negative for COVID-19 in nasopharyngeal swab	89
Senescence mechanisms and targets in the heart	87
NLRP3 inflammasome as a key driver of vascular disease	81
Off-target effects of sodium-glucose co-transporter 2 blockers: empagliflozin does not inhibit Na+/H+ exchanger-1 or lower [Na+]i in the heart	76
Obesity, kidney dysfunction, and inflammation: interactions in hypertension	76
Environmental risk factors and cardiovascular diseases: a comprehensive expert review	76
The role of CD36 in cardiovascular disease	72

Towards standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function	72
Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart	69
Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes	66
NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias	64
mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification	63
COVID-19 as a cardiovascular disease: the potential role of chronic endothelial dysfunction	63
Pathophysiology of atrial fibrillation and chronic kidney disease	61
Inflammation and cardiovascular diseases: lessons from seminal clinical trials	57
Targeting mitochondrial fission as a potential therapeutic for abdominal aortic aneurysm	56
Mechanism of succinate efflux upon reperfusion of the ischaemic heart	56
Loss of Yap/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function	55
The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis	54
Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications	53
Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working	53
Emerging views of statin pleiotropy and cholesterol lowering	53
Organ-on-a-chip technology: a novel approach to investigate cardiovascular diseases	52
Ketones can become the major fuel source for the heart but do not increase cardiac efficiency	52
Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group	51
Effect of inclisiran, the small-interfering RNA against proprotein convertase subtilisin/kexin type 9, on platelets, immune cells, and immunological biomarkers: a pre-specified analysis from ORION-1	51
Plasma levels of trimethylamine-N-oxide can be increased with ‘healthy’ and ‘unhealthy’ diets and do not correlate with the extent of atherosclerosis but with plaque instability	51
Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets	50
Critical examination of mechanisms underlying the reduction in heart failure events with SGLT2 inhibitors: identification of a molecular link between their actions to stimulate erythrocytosis and to a	50
Association of cardiometabolic microRNAs with COVID-19 severity and mortality	49
Physiological and pathological roles of protein kinase A in the heart	48
The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and cardiovascular disease	47
Heritable arrhythmia syndromes associated with abnormal cardiac sodium channel function: ionic and non-ionic mechanisms	47
Computational models of atrial fibrillation: achievements, challenges, and perspectives for improving clinical care	47
Loss of SIRT1 in diabetes accelerates DNA damage-induced vascular calcification	46
Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Funct	46
Risk factors profile of young and older patients with myocardial infarction	46
Inflammation during the life cycle of the atherosclerotic plaque	45
Heart failure with preserved ejection fraction: insights into diagnosis and pathophysiology	45
Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles	44
Single-cell RNA-sequencing reveals profound changes in circulating immune cells in patients with heart failure	44
Risk factors for myocardial injury and death in patients with COVID-19: insights from a cohort study with chest computed tomography	44
Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications	44
Cell therapy in patients with heart failure: a comprehensive review and emerging concepts	44
High spatial endothelial shear stress gradient independently predicts site of acute coronary plaque rupture and erosion	43
Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart	43
PCSK9 and LRP5 in macrophage lipid internalization and inflammation	42
Dietary recommendations for prevention of atherosclerosis	42
Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis	42
Single-cell RNA sequencing profiling of mouse endothelial cells in response to pulmonary arterial hypertension	42
Sustained subcutaneous delivery of secretome of human cardiac stem cells promotes cardiac repair following myocardial infarction	41
Transthyretin cardiac amyloidosis	40
Vascular endothelial tissue factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis	40
Abnormalities in sodium current and calcium homoeostasis as drivers of arrhythmogenesis in hypertrophic cardiomyopathy	40
Altered atrial cytosolic calcium handling contributes to the development of postoperative atrial fibrillation	40
Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart	40
Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: a prospective, placebo-controlled randomized trial (EVAPORATE): interim	39

How machine learning is impacting research in atrial fibrillation: implications for risk prediction and future management	39
The long and winding road of cardiomyocyte maturation	39
Regenerative potential of epicardium-derived extracellular vesicles mediated by conserved miRNA transfer	39
From RESCUE to ZEUS: will interleukin-6 inhibition with ziltivekimab prove effective for cardiovascular event reduction?	39
Sodium activates human monocytes via the NADPH oxidase and isolevuglandin formation	38
Non-coding RNAs: update on mechanisms and therapeutic targets from the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart	38
Relationship between lipoproteins, thrombosis, and atrial fibrillation	38
Circulating uromodulin inhibits vascular calcification by interfering with pro-inflammatory cytokine signalling	37
Quantifying technical confounders in microbiome studies	37
Sodium-glucose co-transporter 2 inhibitor empagliflozin inhibits the cardiac Na+/H+ exchanger 1: persistent inhibition under various experimental conditions	36
The inflammation-resolution promoting molecule resolvin-D1 prevents atrial proarrhythmic remodelling in experimental right heart disease	36
Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling	36
Myocardin-related transcription factor A regulates integrin beta 2 transcription to promote macrophage infiltration and cardiac hypertrophy in mice	36
The glycocalyx core protein Glypican 1 protects vessel wall endothelial cells from stiffness-mediated dysfunction and disease	36
Titin (TTN): from molecule to modifications, mechanics, and medical significance	35
Association of COVID-19 with short- and long-term risk of cardiovascular disease and mortality: a prospective cohort in UK Biobank	35
Efficacy and limitations of senolysis in atherosclerosis	35
Arrhythmogenic cardiomyopathy: pathogenesis, pro-arrhythmic remodelling, and novel approaches for risk stratification and therapy	34
Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications	33
Exercise effects on cardiovascular disease: from basic aspects to clinical evidence	33
Cardiomyocyte ageing and cardioprotection: consensus document from the ESC working groups cell biology of the heart and myocardial function	33
Sex differences in cardiorespiratory fitness are explained by blood volume and oxygen carrying capacity	33
Neuroscientific therapies for atrial fibrillation	33
Impact of protein glycosylation on lipoprotein metabolism and atherosclerosis	33
Ventricular fibrillation mechanism and global fibrillatory organization are determined by gap junction coupling and fibrosis pattern	32
VE-PTP inhibition elicits eNOS phosphorylation to blunt endothelial dysfunction and hypertension in diabetes	32
The role of autophagy in cardiovascular pathology	32
TNAP as a therapeutic target for cardiovascular calcification: a discussion of its pleiotropic functions in the body	32
Effect of chronic exercise in healthy young male adults: a metabolomic analysis	32
The European/International Fibromuscular Dysplasia Registry and Initiative (FEIRI)—clinical phenotypes and their predictors based on a cohort of 1000 patients	32
Soil and water pollution and human health: what should cardiologists worry about?	32
From organic and inorganic phosphates to valvular and vascular calcifications	32
Dietary carbohydrates restriction inhibits the development of cardiac hypertrophy and heart failure	32
Remote ischaemic preconditioning ameliorates anthracycline-induced cardiotoxicity and preserves mitochondrial integrity	31
Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis	31
The Chief Scientist Office Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) study	31
Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it	31
Hydralazine protects the heart against acute ischaemia/reperfusion injury by inhibiting Drp1-mediated mitochondrial fission	30
Role of oxidative stress in calcific aortic valve disease and its therapeutic implications	30
Circulating microRNAs predispose to takotsubo syndrome following high-dose adrenaline exposure	30
Heterogeneity of immune cells in human atherosclerosis revealed by scRNA-Seq	30
Integrated single-cell analysis-based classification of vascular mononuclear phagocytes in mouse and human atherosclerosis	30
Metformin directly suppresses atherosclerosis in normoglycaemic mice via haematopoietic adenosine monophosphate-activated protein kinase	30
Metabolic alterations in a rat model of takotsubo syndrome	30
Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on Myocardial Function and the ESC Working	30
Dynamics of monocyte-derived macrophage diversity in experimental myocardial infarction	29
Inside the heart of COVID-19	29
Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics	29
Coronary microcirculation damage in anthracycline cardiotoxicity	29
Single-cell dual-omics reveals the transcriptomic and epigenomic diversity of cardiac non-myocytes	29
Single-cell transcriptomic analyses of cardiac immune cells reveal that Rel-driven CD72-positive macrophages induce cardiomyocyte injury	29
Role of R-spondin 2 in arterial lymphangiogenesis and atherosclerosis	29
The chemokine CXCL14 mediates platelet function and migration via direct interaction with CXCR4	29
Inclisiran for the treatment of hypercholesterolaemia: implications and unanswered questions from the ORION trials	29
High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension	28
Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153 152 middle-aged individuals	28
Zinc ameliorates human aortic valve calcification through GPR39 mediated ERK1/2 signalling pathway	27
Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions	27
Reciprocal organ interactions during heart failure: a position paper from the ESC Working Group on Myocardial Function	27
Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment	27
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis	27
Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?	27
Vascular histopathology and connective tissue ultrastructure in spontaneous coronary artery dissection: pathophysiological and clinical implications	27
A novel method for measuring absolute coronary blood flow and microvascular resistance in patients with ischaemic heart disease	26
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up	26
Single-cell RNA sequencing reveals cell type- and artery type-specific vascular remodelling in male spontaneously hypertensive rats	26
Caloric restriction mimetics for the treatment of cardiovascular diseases	26
EDIL3 deficiency ameliorates adverse cardiac remodelling by neutrophil extracellular traps (NET)-mediated macrophage polarization	26
Adoptive transfer of CX3CR1 transduced-T regulatory cells improves homing to the atherosclerotic plaques and dampens atherosclerosis progression	26
Role of the vascular endothelial sodium channel activation in the genesis of pathologically increased cardiovascular stiffness	26
Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies	26
Rituximab in patients with acute ST-elevation myocardial infarction: an experimental medicine safety study	26
Inhibiting cardiac myeloperoxidase alleviates the relaxation defect in hypertrophic cardiomyocytes	26
The vasculature: a therapeutic target in heart failure?	25
A combined microRNA and target protein-based panel for predicting the probability and severity of uraemic vascular calcification: a translational study	25
Central role of c-Src in NOX5- mediated redox signalling in vascular smooth muscle cells in human hypertension	25
Two-hit mechanism of cardiac arrhythmias in diabetic hyperglycaemia: reduced repolarization reserve, neurohormonal stimulation, and heart failure exacerbate susceptibility	25
Impaired retinal microvascular function predicts long-term adverse events in patients with cardiovascular disease	25
MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling	25
Endothelial cell metabolic memory causes cardiovascular dysfunction in diabetes	25

Human CD16+ monocytes promote a pro-atherosclerotic endothelial cell phenotype via CX3CR1–CX3CL1 interaction	25
COVID-19-related cardiac complications from clinical evidences to basic mechanisms: opinion paper of the ESC Working Group on Cellular Biology of the Heart	25
Interleukin-5-induced eosinophil population improves cardiac function after myocardial infarction	24
New aspects of endocrine control of atrial fibrillation and possibilities for clinical translation	24
Remodelling of adult cardiac tissue subjected to physiological and pathological mechanical load in vitro	24
Mapping the developing human cardiac endothelium at single-cell resolution identifies MECOM as a regulator of arteriovenous gene expression	24
Low-intensity pulsed ultrasound ameliorates cardiac diastolic dysfunction in mice: a possible novel therapy for heart failure with preserved left ventricular ejection fraction	24
Human influenza A virus causes myocardial and cardiac-specific conduction system infections associated with early inflammation and premature death	24
Endothelial barrier integrity in COVID-19-dependent hyperinflammation: does the protective facet of platelet function matter?	24
Different cardiovascular and pulmonary phenotypes for single- and double-knock-out mice deficient in BMP9 and BMP10	24
G protein-coupled receptor kinase 5 (GRK5) contributes to impaired cardiac function and immune cell recruitment in post-ischemic heart failure	24
Human-induced pluripotent stem cells in cardiovascular research: current approaches in cardiac differentiation, maturation strategies, and scalable production	24
The impact of aircraft noise on vascular and cardiac function in relation to noise event number: a randomized trial	24
Ketone therapy for heart failure: current evidence for clinical use	23
Cyclic GMP modulating drugs in cardiovascular diseases: mechanism-based network pharmacology	23
The VWF/LRP4/αVβ3-axis represents a novel pathway regulating proliferation of human vascular smooth muscle cells	23
SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy	23
Sequence meets function—microbiota and cardiovascular disease	23
Network medicine in Cardiovascular Research	23
Plasma high-density lipoprotein cholesterol and risk of dementia: observational and genetic studies	23
Stretch-induced sarcoplasmic reticulum calcium leak is causatively associated with atrial fibrillation in pressure-overloaded hearts	23
Gene editing reverses arrhythmia susceptibility in humanized PLN-R14del mice: modelling a European cardiomyopathy with global impact	23
Inhibition of xanthine oxidase in the acute phase of myocardial infarction prevents skeletal muscle abnormalities and exercise intolerance	23
Nicotine promotes vascular calcification via intracellular Ca2+-mediated, Nox5-induced oxidative stress, and extracellular vesicle release in vascular smooth muscle cells	23
Innate and adaptive immunity: the understudied driving force of heart valve disease	23
Cardiac cellularity is dependent upon biological sex and is regulated by gonadal hormones	23
Autonomic innervation of the carotid body as a determinant of its sensitivity: implications for cardiovascular physiology and pathology	22
NRF2 is a key regulator of endothelial microRNA expression under proatherogenic stimuli	22
Progress in cardiac research: from rebooting cardiac regeneration to a complete cell atlas of the heart	22
Cardio-metabolic consequences of dietary carbohydrates: reconciling contradictions using nutritional geometry	22
Impairment of mitophagy and autophagy accompanies calcific aortic valve stenosis favouring cell death and the severity of disease	22
The complex network of mTOR signalling in the heart	22
Concurrent diabetes and heart failure: interplay and novel therapeutic approaches	22
Molecular mechanisms and clinical implications of multiple forms of mitophagy in the heart	22
Chronically elevated branched chain amino acid levels are pro-arrhythmic	22
Addressing global disparities in blood pressure control: perspectives of the International Society of Hypertension	22
Management of cardiac fibrosis is the largest unmet medical need in heart failure	22
Chitinase 3 like 1 is a regulator of smooth muscle cell physiology and atherosclerotic lesion stability	22
Determining a minimum set of variables for machine learning cardiovascular event prediction: results from REFINE SPECT registry	22
Asymmetric Hapln1a drives regionalized cardiac ECM expansion and promotes heart morphogenesis in zebrafish development	22
Additive protective effects of sacubitril/valsartan and bosentan on vascular remodelling in experimental pulmonary hypertension	22
Natriuretic peptide pathways in heart failure: further therapeutic possibilities	21
The healing myocardium mobilizes a distinct B-cell subset through a CXCL13-CXCR5-dependent mechanism	21
Stimulating pro-reparative immune responses to prevent adverse cardiac remodelling: consensus document from the joint 2019 meeting of the ESC Working Groups of cellular biology of the heart and myocar	21
MicroRNA-mediated vascular intercellular communication is altered in chronic kidney disease	21
Sex differences in acute cardiovascular care: a review and needs assessment	21
HDAC1: an environmental sensor regulating endothelial function	21
Ulk1-dependent alternative mitophagy plays a protective role during pressure overload in the heart	21
Mechanisms, therapeutic implications, and methodological challenges of gut microbiota and cardiovascular diseases: a position paper by the ESC Working Group on Coronary Pathophysiology and Microcircul	21
Coronary artery disease patients without standard modifiable risk factors (SMuRFs)- a forgotten group calling out for new discoveries	20
Cardiovascular effects of non-insulin glucose-lowering agents: a comprehensive review of trial evidence and potential cardioprotective mechanisms	20
Human cardiosphere-derived stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 recept	20
Non-invasive transcutaneous vagal nerve stimulation improves myocardial performance in doxorubicin-induced cardiotoxicity	20
Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice	20
Gene therapy for inherited arrhythmias	20
Approaches to treat pulmonary arterial hypertension by targeting BMPR2: from cell membrane to nucleus	20
Diet-induced dyslipidemia induces metabolic and migratory adaptations in regulatory T cells	20
Flow-mediated dilation reference values for evaluation of endothelial function and cardiovascular health	20
Recent advances in the role of the adenosinergic system in coronary artery disease	20
Emerging epigenetic therapies of cardiac fibrosis and remodelling in heart failure: from basic mechanisms to early clinical development	20
Rapid neutrophil mobilization by VCAM-1+ endothelial cell-derived extracellular vesicles	20
Age-related enhanced degeneration of bioprosthetic valves due to leaflet calcification, tissue crosslinking, and structural changes	20
Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload	20
Two-faced Janus: the dual role of macrophages in atherosclerotic calcification	20
Heart–gut microbiota communication determines the severity of cardiac injury after myocardial ischaemia/reperfusion	19
Therapeutic targeting of inflammation in hypertension: from novel mechanisms to translational perspective	19
Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy	19
Extracellular histones are a target in myocardial ischaemia–reperfusion injury	19
Functional and structural adaptations of the coronary macro- and microvasculature to regular aerobic exercise by activation of physiological, cellular, and molecular mechanisms: ESC Working Group on C	19
Empagliflozin inhibits excessive autophagy through the AMPK/GSK3β signalling pathway in diabetic cardiomyopathy	19
Heritable arrhythmias associated with abnormal function of cardiac potassium channels	19
Association between BNT162b2 or CoronaVac COVID-19 vaccines and major adverse cardiovascular events among individuals with cardiovascular disease	19
Cardiac metabolism in HFpEF: from fuel to signalling	19
Pharmacological inhibition of adipose tissue adipose triglyceride lipase by Atglistatin prevents catecholamine-induced myocardial damage	19
The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure	18
Central and peripheral sympathetic activation in heart failure	18
No sex-related differences in infarct size, no-reflow, and protection by ischaemic pre-conditioning in Göttingen minipigs	18
Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice	18
Role of interleukin-23/interleukin-17 axis in T-cell-mediated actions in hypertension	18
Deletion of fibroblast activation protein provides atheroprotection	18
Neuroimmune interactions in cardiovascular diseases	18
Interleukin-7 and interleukin-15 drive CD4+CD28null T lymphocyte expansion and function in patients with acute coronary syndrome	18
Remdesivir induces persistent mitochondrial and structural damage in human induced pluripotent stem cell-derived cardiomyocytes	18
Failure to vasodilate in response to salt loading blunts renal blood flow and causes salt-sensitive hypertension	18
Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench to bedside	18
Loss of autophagy protein ATG5 impairs cardiac capacity in mice and humans through diminishing mitochondrial abundance and disrupting Ca2+ cycling	18
Cell senescence: basic mechanisms and the need for computational networks in vascular ageing	18
Angiopoietin-1 enhanced myocyte mitosis, engraftment, and the reparability of hiPSC-CMs for treatment of myocardial infarction	18
Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study	18
SPEG: a key regulator of cardiac calcium homeostasis	18
Rare loss-of-function mutations of PTGIR are enriched in fibromuscular dysplasia	18
Genome-wide association studies of cardiac electrical phenotypes	17
Co-expression of calcium and hERG potassium channels reduces the incidence of proarrhythmic events	17
Dilated cardiomyopathy-linked heat shock protein family D member 1 mutations cause up-regulation of reactive oxygen species and autophagy through mitochondrial dysfunction	17
Trimethylamine N-oxide induces osteogenic responses in human aortic valve interstitial cells in vitro and aggravates aortic valve lesions in mice	17